Regulatory & Legal

With 18 years at the commission and a deep legal background, Deanna Steblyk’s appointment signals a focus on stability and investor protection.

A new alliance aims to overhaul Alzheimer's research, demanding a precision approach for the 65% of patients carrying the high-risk APOE4 gene.

After a six-month stalemate, 750 striking nurses are taking their fight with Henry Ford Genesys to Lansing, drawing in top political figures.

As severe storms cause power outages, a hidden threat emerges. Learn how to protect your family from carbon monoxide, the "invisible killer."

With an $8.3M award to Reaction Dynamics, Canada's $105M 'Launch the North' initiative aims to end reliance on foreign rockets and build its own.

The Jed Foundation issues a stark 2026 alert, warning that a storm of unchecked AI, social isolation, and funding cuts is fueling a youth mental health crisis.

A massive new battery project in Bergen County aims to solve NJ's power woes, promising more reliable electricity and relief from soaring energy prices.

A landmark study of 20,000 UK shoppers reveals the nation's most trusted brands, showing why names like Heinz and Durex still dominate in a complex market.

Private firm Top Aces will lead Argentina’s transition to F-16s, a key step in a major air force modernization with deep geopolitical implications.

A $12.45M deal for a uranium plant collapses, but Radnostix sees a silver lining, believing the asset is now more valuable in a booming nuclear market.

A new study at GBMC tests an AI-powered artificial larynx, offering hope to millions of voiceless ICU patients and aiming to transform critical care.

The near-commercial lithium company adds a retired Marine general and a top policy architect to navigate Washington's critical minerals strategy.

The firm posted a massive $66M profit, but a $77M non-cash gain and a move to OTC markets urge investors to look beyond the impressive headlines.

In a landmark $1.1B deal with Trafigura, Nth Cycle’s modular tech and US/EU expansion signal a new era for secure, recycled critical minerals.

With a new growth chief and a shelf of journalism awards, health media outlet STAT is betting its decade of reporting can fuel its next business chapter.

A new wave of big data analytics promises fairer auto insurance by analyzing how people drive, not just where they live. But does this come at a cost to privacy?

A new needle-delivered electrode could make advanced nerve stimulation less invasive, opening up a massive market beyond spinal cord surgery.

With its lead autoimmune drug nearing FDA review and a new $250M in funding, Zenas BioPharma prepares for a major leap from R&D to market.

Inc. names Tiffany Whitlow to its Female Founders 500, validating Acclinate's model of making inclusive clinical research a profitable, high-growth venture.

The junior miner's inclusion in the GDXJ and strategic move to Miami aim to boost investor visibility and streamline access to its Colombian gold projects.